Marcos Gómez‐Revuelta

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone

Marcos Gómez‐Revuelta, José María Pelayo‐Terán, María Juncal‐Ruíz et al. · The International Journal of Neuropsychopharmacology · 2020 · 72 citations · Full text

Understanding sex differences in long-term outcomes after a first episode of psychosis

Rosa Ayesa‐Arriola, Víctor Ortiz‐García de la Foz, Esther Setién‐Suero et al. · Schizophrenia · 2020 · 57 citations · Full text

Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients

Javier Vázquez-Bourgón, Víctor Ortiz‐García de la Foz, Irene Suárez‐Pereira et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2019 · 24 citations · Full text

Cannabis Use, Substance Use, Health Sciences +12

A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients

Javier Vázquez-Bourgón, Miguel Ibáñez Alario, Jacqueline Mayoral-van Son et al. · European Neuropsychopharmacology · 2020 · 24 citations

Psychiatry, Psychotic Disorder, 3-Year Prospective Study +9

Duration of active psychosis and functional outcomes in first-episode non-affective psychosis

José María Pelayo‐Terán, Virginia Gajardo-Galán, Marcos Gómez‐Revuelta et al. · European Psychiatry · 2018 · 23 citations · Full text